Aurora Cannabis Inc. (ACB) vs Rocket Pharmaceuticals, Inc. (RCKT)

A side-by-side comparison of Aurora Cannabis Inc. and Rocket Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ACB vs RCKT

growth of $100 · dividends reinvested · last 10y
ACB -97.3% (-30.2%/yr)RCKT -92.9% (-23.3%/yr)RCKT compounded faster over this window
0200400600800Start $10020182020202220242026$3$7
ACB RCKT

ACB vs RCKT: by the numbers

  • •ACB is the larger company ($281M vs $270M market cap).
  • •Both run net losses; RCKT's is the smaller (0.00% vs -38.13% net margin).

Metrics side by side

Valuation

MetricACBRCKT
P/S ratio1.35N/A
P/B ratio0.760.73

Profitability

MetricACBRCKT
Gross margin42.62%0.00%
Operating margin-14.55%0.00%
Net margin-38.13%0.00%
ROE-21.41%-4.68%
ROIC-15.69%-48.92%

Growth (annualized)

MetricACBRCKT
Revenue CAGR (5Y)1.68%N/A
Total return CAGR (5Y)-42.83%-38.33%

Frequently asked

How have ACB and RCKT total returns compared?
Over the past 10 years, ACB delivered -30.23% and RCKT delivered -23.48% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.